Adamas Pharmaceuticals Inc 4/A
4/A · Adamas Pharmaceuticals Inc · Filed Feb 23, 2017
Insider Transaction Report
Form 4/AAmended
Went Gregory T
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Stock
2016-06-15$1.88/sh+204,900$384,188→ 263,658 total